Sign inGet started

Wong Brian Russell

Insider CIK 1646110 · RAPT President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-05218,250— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-058,334— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0525,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-05371,875— $0265,625SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0531,250— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0537,500— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0518,750— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0510,417— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-057,500— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2026-03-032026-03-0534,375— $00SEC↗
RAPT RAPT Therapeutics, Inc. U Tender2026-03-032026-03-0564,102— $00SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2025-06-202025-06-24637,500— $0637,500SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2025-01-302025-02-031,746,000— $01,746,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-15300,000— $0300,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-1560,000— $060,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-15275,000— $0275,000SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-15275,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-15250,000— $0250,000SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-15250,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-1560,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-15300,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-15150,000— $0150,000SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-15150,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. D To issuer deriv2024-11-132024-11-1583,333— $00SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-11-132024-11-1583,333— $083,333SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2024-01-312024-02-01275,000— $0275,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2023-01-312023-02-02250,000— $0250,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2022-01-282022-02-14300,000— $0300,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2021-01-282021-02-01150,000— $0150,000SEC↗
RAPT RAPT Therapeutics, Inc. S Sale2020-10-122020-10-1320,000$40.05 $801.0K337,000SEC↗
RAPT RAPT Therapeutics, Inc. P Buy2020-09-232020-09-232,000$30.06 $60.1K357,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2020-01-302020-01-3160,000— $060,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award2020-01-302020-01-3122,000— $0147,000SEC↗
RAPT RAPT Therapeutics, Inc. C Conversion deriv2019-11-042019-11-04150,000— $00SEC↗
RAPT RAPT Therapeutics, Inc. C Conversion2019-11-042019-11-0425,000— $0355,000SEC↗
RAPT RAPT Therapeutics, Inc. P Buy2019-11-042019-11-0425,000$12.00 $300.0K125,000SEC↗
RAPT RAPT Therapeutics, Inc. A Award deriv2019-10-302019-11-0183,333— $083,333SEC↗